Navigation Links
Midmark Corporation Makes Donation to The Ohio State University College of Medicine to Foster Efficient, Effective Patient Care
Date:11/18/2013

(PRWEB) November 18, 2013

Midmark Corporation, a leading medical solutions provider and trusted leader in digital diagnostic devices for ambulatory care, recently announced a donation to The Ohio State University’s College of Medicine - Wexner Medical Center.

Midmark equipment was installed in two training centers – the Clinical Skills Education and Assessment Center – in the College of Medicine at the Wexner Medical Center. The donation of Midmark equipment, including Ritter 223 Barrier-Free® exam tables, mobile treatment carts, Care Exchange™ 6206 workstations, a Ritter M11 UltraClave® Automatic Sterilizer and more, will enhance new and existing instructional programs in the Center’s critical care bays and patient simulation areas.

“We’re grateful for Midmark’s support of our program and our students,” said Sheryl Pfeil, M.D., Medical Director, The Ohio State University's Clinical Skills Education and Assessment Center. “The company’s continued support allows our students to be trained on equipment currently being used in hospitals and clinics, and to develop the skills they need to deliver efficient, effective patient care.”

Midmark has partnered with OSU on various projects, including clinic renovations for its College of Dentistry, now named the “Midmark Emergency Care Clinic.” The company has also worked with staff at OSU’s Thomas E. Rardin Family Practice Center on exam room workflow and product research, as well as The Ohio State Veterinary Medical Center to increase education in periodontal disease and pet dental care.

“We support OSU and the Center’s mission to promote and provide high quality clinical education and reliable assessment of skills and procedures to advance patient care,” said Kurt Forsthoefel, marketing director, medical products and services, Midmark.

Read the full story at http://ww
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. LAN Infotech Achieves a Microsoft Silver Midmarket Solution Provider Competency in the Microsoft Partner Network
2. Cymbet Corporation Teams with Opto-Sensor
3. Countervail Corporation Receives Additional $5.4 Million from BARDA For Continued Development of Medical Countermeasure to Nerve Agents
4. Agein Corporation, a Leading Anti-Aging Company, Responds to Research Showing More Men Turning to Cosmetic Surgery to Increase Work Opportunities
5. Rich Products Corporation Streamlines their Production Process with Seamless Workflow, Media Asset Management and Online Proofing
6. ZeptoMetrix Corporation (ZMC) in Collaboration with CytoSignet, Inc. to Offer Proactive, Patented* and Extensive Bed Bug Detection Products
7. Divine Corporation, Developers of Divine 9 Personal Lubricants with Carragel, Changes the Company Name to CarraShield Labs, Inc.
8. Agein Corporation Congratulates Wal-Mart & Target for Ban of Chemicals in Products
9. E-Waste Event, Hosted by: Miller Recycling Corporation
10. Pionetics® Corporation Signs Rayne of Amarillo as a New LINX® Distributor
11. Vidacare Corporation Launches New iOS App for OnControl Powered Bone Access System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Angeles, CA (PRWEB) March 03, 2015 ... Boost , a fast weight loss product that is ... country. This is because it contains ingredients that help ... Boost is a new combination diet product thought to ... Metabolism Boost contains three ingredients, all directed at ...
(Date:3/3/2015)... Getting to the truth of the matter is ... at stake. So when it comes to physical therapy – ... – it’s vital to separate fact from fiction in order ... Sridhar Yalamanchili, PT, MSPT, and Director of Rehabilitation at ... nationwide survey by the American Physical Therapy Association (APTA) revealed ...
(Date:3/3/2015)... Spain (PRWEB) March 03, 2015 The authors ... best health care for the future is a good and ... by Xlibris UK) the authors have a created an ingenious ... & cooked vegetarian & vegan meals. , “Crude Food” ... food intolerances and allergies, mainly caused by over processed ...
(Date:3/3/2015)... HealthCarePoint (HCP) , the ... today that it has completed development of the ... Standards Consortium (CDISC). HCP will continue to provide ... training and certifications globally. HCP’s in-kind services will ... as well as development of dynamic identification for ...
(Date:3/3/2015)... 03, 2015 Motion Graphics ... of a new plugin FCPX3D Confetti designed exclusively for ... exploding transition using confetti particles inside FCPX,” said Christina ... FCPX3D Confetti transition, users will have fun as they ... from one clip to the next with 3D tumbling ...
Breaking Medicine News(10 mins):Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 2Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 3Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 4Health News:Separating Fact from Fiction about Physical Therapy 2Health News:Separating Fact from Fiction about Physical Therapy 3Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 2Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 3Health News:HealthCarePoint Completes CDISC BlueCloud Transnational Commerce Through In-kind Donations 2Health News:HealthCarePoint Completes CDISC BlueCloud Transnational Commerce Through In-kind Donations 3Health News:A new Confetti Generator entitled FCPX3D Confetti was released today from Pixel Film Studios for Final Cut Pro X 2
... News) -- Premature infants have fewer types of bacteria in ... However, the bacteria and other microbes often found ... researchers from Duke University Medical Center noted. "You see ... they seem to be stuck -- they have fewer types ...
... function were common and long-lasting during the first ... to a new study from Johns Hopkins University ... risk factor for impaired physical function. "Early ... evaluated as a potential,intervention to improve long-term outcomes ...
... , THURSDAY, Dec. 8 (HealthDay News) -- Increased consumption ... of breast cancer recurrence, new research finds. Researcher ... University of California, San Diego, looked at changes in ... potatoes, that breast cancer survivors ate over a one-year ...
... quantifying the amount of three different HER growth proteins, ... breast cancer , did not predict a patient,s outcome ... Herceptin, say Mayo Clinic researchers. HER2-positive breast cancer gets ... factor receptor 2 that promotes cancer cell growth. ...
... By Serena Gordon HealthDay Reporter , THURSDAY, Dec. ... the risk of stroke dropped about 22 percent in people ... These people didn,t yet have high blood pressure, but they ... significant reduction in the rate of heart attacks for people ...
... used to spot where people live, satellite images of ... festering among them, too, according to new research. ... Dec. 9 that nighttime-lights imagery presents a new ... revealing the population boom that typically coincides with seasonal ...
Cached Medicine News:Health News:Preemies Infected With More Dangerous Types of Bacteria: Study 2Health News:Depressive symptoms and impaired physical function are frequent and long-lasting after ALI 2Health News:Starchy Foods May Boost Risk of Breast Cancer Recurrence 2Health News:Starchy Foods May Boost Risk of Breast Cancer Recurrence 3Health News:Proteins do not predict outcome of herceptin treatment in HER2-positive breast cancer 2Health News:Treating Prehypertension Lowers Stroke Risk: Study 2Health News:Treating Prehypertension Lowers Stroke Risk: Study 3Health News:Princeton study: Nighttime images help track disease from the sky 2Health News:Princeton study: Nighttime images help track disease from the sky 3Health News:Princeton study: Nighttime images help track disease from the sky 4Health News:Princeton study: Nighttime images help track disease from the sky 5Health News:Princeton study: Nighttime images help track disease from the sky 6
(Date:3/3/2015)... -- Although lung cancer is the third most prevalent ... drugs in the market for its treatment. Further, popular ... patent expiry in 2015 and 2017 respectively. As such, ... drug manufacturers are vying to tap into. Approximately 130 ... (SCLC) and non-small cell lung cancer (NSCLC) are in ...
(Date:3/3/2015)... ROCKVILLE, Md. , March 3, 2015  CASI ... company dedicated to the acquisition, development and commercialization of ... for the global market with a commercial focus on ... K. Ren , Ph.D., CASI,s Chief Executive Officer, will ... ROTH Conference, to be held March 8-11 in Dana ...
(Date:3/3/2015)... 2015  Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... that address unmet medical needs in the areas ... has received a positive recommendation from the Data ... company,s Phase 2 study evaluating SGX942, a first-in-class ... oral mucositis in patients undergoing chemoradiation (CRT) therapy ...
Breaking Medicine Technology:Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 2Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 3CASI Pharmaceuticals To Present At The 27th Annual ROTH Conference 2Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6
... IRVINE, Calif.--(BUSINESS WIRE)--Apr 30, 2007 - Cobalis ... specializing in,anti-allergy medications, today announced it has ... that it would need,more time to combine ... single,database before un-blinding and conducting the statistical ...
... WIRE)--Apr 30, 2007 - Hemispherx Biopharma,Inc. (AMEX: ... of Immunology, April 2007) that explains the ... (Poly I : Poly C(12)U), a double-stranded ... Fatigue Syndrome and as an,adjuvant to other ...
Cached Medicine Technology:Cobalis Expects to Report Phase III Top-Line Results in May 2New Report Illuminates Ampligen's Unique Mechanism of Action 2New Report Illuminates Ampligen's Unique Mechanism of Action 3New Report Illuminates Ampligen's Unique Mechanism of Action 4
For the quantitative in vitro determination of Alkaline Phosphatase in serum or plasma....
... EMR,systems require you to,change the ... only,electronic patient charting,solution designed to ... around,five specific criteria to,enhance overall ... you to see,more patients in ...
... StatStrip point-of-care glucose monitor elevates bedside glucose ... performance that approaches the quality of central ... well glucose measuring strip technology. Current ... Novas exclusive Multi-Well system measures and corrects ...
... EMS provides service to companies in many ... stores and restaurants.There are no hidden charges at ... equipment and service are among the lowest in ... array of services ranging from MasterCard/Visa processing to ...
Medicine Products: